XML 46 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Grant Revenue - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 19, 2022
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Oct. 04, 2024
Sep. 01, 2024
Grant [Member]              
Disaggregation of Revenue [Line Items]              
Revenue recognized   $ 1,456,000 $ 1,240,000 $ 4,412,000 $ 3,600,000    
CPRIT Contract [Member]              
Disaggregation of Revenue [Line Items]              
Grant funding term 3 years            
CPRIT grant funding term, description       The CPRIT Grant is subject to customary CPRIT funding conditions, including, but not limited to, a matching fund requirement (one dollar for every two dollars awarded by CPRIT), revenue sharing obligations upon commercialization of rhenium (186Re) obisbemeda based on specific dollar thresholds and tiered low single digit royalty rates until CPRIT receives the aggregate amount of 400% of the proceeds awarded under the CPRIT Grant, and certain reporting requirements.      
Contract effective date Aug. 31, 2022            
Contract termination date Aug. 30, 2025            
Percentage of aggregate amount of proceeds awarded under CPRIT grant 400.00%            
Percentage of grant proceeds with interest not exceed annually 5.00%            
CPRIT Contract [Member] | Grant [Member]              
Disaggregation of Revenue [Line Items]              
Revenue recognized   $ 1,500,000 $ 4,400,000 $ 1,200,000 $ 3,600,000    
Department of Defense Award [Member]              
Disaggregation of Revenue [Line Items]              
Research and development award period             3 years
Grant revenue       $ 0      
Department of Defense Award [Member] | Subsequent Event              
Disaggregation of Revenue [Line Items]              
First payment received           $ 900,000  
Congressionally Directed Medical Research Programs [Member]              
Disaggregation of Revenue [Line Items]              
Amount to be received as award for research and development             $ 3,000,000